INS and Hyperglycemia: Talin-1 defficiency in β-cells leads to hyperglycemia in mice upon glucose challenge, which is primarily attributed to impaired glucose-stimulated insulin secretion (GSIS) and reduced β-cell mass, rather than peripheral insulin resistance.